HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

One-stage treatment of congenital severely dislocated hips in older children through various acetabuloplasty techniques: 22 children followed for 1-5 years.

AbstractBACKGROUND:
There is no consensus regarding the best treatment for children with late diagnosis of congenital hip dislocation.
PATIENTS AND METHODS:
This retrospective study involved 29 hips in 22 children (19 girls) with an age range of 3-14 years, who had been operated with various techniques for congenital hip dislocation between 1998 and 2002. 6 patients had right, 9 patients had left, and 7 patients had bilateral congenital hip dislocation. The mean length of follow-up was 3 (1-5) years.
RESULTS:
While the mean acetabular index was 53 degrees (35-65) preoperatively, at the last follow-up it was 30 degrees (15-50). 27 hips were type 4 and 2 hips were type 3 by Tönnis criteria. Satisfactory reduction (Severin Class I) had been achieved in 19 hips at the follow-up radiography, and they developed no osteonecrosis. The outcome was successful in children under 7 years of age, but problems encountered in those over 7 increased unless sufficient reduction had been achieved.
INTERPRETATION:
Age at treatment of late-diagnosed congenital hip dislocation appears to be important for outcome.
AuthorsMetin Dogan, Murat Bozkurt, Hakan Sesen, Hasan Yildirim
JournalActa orthopaedica (Acta Orthop) Vol. 76 Issue 2 Pg. 212-9 (Apr 2005) ISSN: 1745-3674 [Print] Sweden
PMID16097546 (Publication Type: Journal Article)
Topics
  • Acetabulum (diagnostic imaging, pathology, surgery)
  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Hip Dislocation, Congenital (diagnostic imaging, pathology, surgery)
  • Hip Joint (diagnostic imaging, pathology)
  • Humans
  • Male
  • Orthopedic Procedures (methods)
  • Radiography
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: